Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Medically Tailored Groceries and Food Resource Coaching [NA]
This clinical trial update reports the completion of a study evaluating the impact of medically tailored groceries and food resource coachin…
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients [Phase 4]
Phase 4 clinical trial evaluating mineralocorticoid receptor antagonists for hypertension in obese patients has completed.
-
CLINICAL_TRIALS trial_result · 2025-07-31Clinical Trial Update: Community-led Strategy to Reduce Cardiovascular Disease Risk Among Conflict-affected Populations [NA]
Community Partners International reports that the trial evaluating a community-led strategy to reduce cardiovascular disease risk in conflic…
-
CLINICAL_TRIALS withdrawal · 2025-07-31Clinical Trial Update: EuroNetrod HTN OFF-Med Study of Renal Denervation With NetrodTM Six-electrode Radiofrequency RDN System [NA]
The EuroNetrod HTN OFF-Med study evaluating the Netrod six-electrode renal denervation system for uncontrolled hypertension has been withdra…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Culturally Adapted Dietary Clinical Trial in PR [NA]
A clinical trial in Puerto Rico is recruiting to evaluate a culturally adapted dietary intervention for adults with type 2 diabetes and obes…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: Evaluation of a Health Literacy Intervention on Patients Suffering From Hypertension in Primary Care [NA]
This clinical trial evaluates a health literacy intervention for patients with hypertension in primary care. The study is not yet recruiting…
-
FDA approval · 2025-07-30FDA Approved: ATENOLOL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Atenolol submitted by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: IV Hydrogen Nanobubbles for Cardiac Function and QoL [NA]
A completed clinical trial evaluating intravenous hydrogen nanobubbles for improving cardiac function and quality of life in patients with c…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Blood Pressure Monitor (KD-595) Clinical Test (Cuff Range: 15-24cm, 22-42cm, 40-48cm)
Completed clinical test update for the KD-595 blood pressure monitor, validating cuff ranges of 15-24 cm, 22-42 cm, and 40-48 cm for accurat…
-
CLINICAL_TRIALS withdrawal · 2025-07-30Clinical Trial Update: Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance [Phase 2]
A Phase 2 trial evaluating a GABA transaminase inhibitor to relieve obesity-induced hyperinsulinemia and insulin resistance has been withdra…
-
CLINICAL_TRIALS trial_result · 2025-07-30Clinical Trial Update: Renal Arterial Denervation in Sympathetic Dysautonomia
A completed clinical trial evaluating renal arterial denervation for hypertension and sympathetic dysautonomia; the update does not report t…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: INTERVENCION Trial [Phase 4]
Phase 4 INTERVENCION trial evaluating treatment for hypertension has completed with results posted in July 2025.
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
A clinical trial by Eko Devices is evaluating deep learning detection of pulmonary hypertension and reduced ejection fraction using a digita…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: A Study Protocol to Assess the Effectiveness of Nurse-Led Telehealth Intervention for Hypertension Control in Nepal [NA]
This study protocol from Kathmandu University explores a nurse-led telehealth intervention to improve hypertension control in Nepal and outl…
-
CLINICAL_TRIALS research · 2025-07-28Clinical Trial Update: Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients [NA]
This clinical trial update describes a pharmacist-led multifaceted intervention intended to improve treatment outcomes in patients with hype…
-
CLINICAL_TRIALS other · 2025-07-28Clinical Trial Update: Effect of Digital Intervention on Self-management of Hypertensive Patients at High Risk of Stroke [NA]
This entry describes a clinical trial assessing a digital intervention to improve self-management in patients with hypertension at high risk…
-
FDA approval · 2025-07-25FDA Approved: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic olmesartan medoxomil and hydrochlorothiazide tablet under an original ANDA.
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Lifestyle Medicine: Establishing Clinical Approaches to Chronic Disease for Rural Patients [NA]
A clinical trial led by the West Virginia School of Osteopathic Medicine is evaluating lifestyle medicine approaches to chronic disease mana…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: High-Intensity Interval Versus Moderate-Intensity Continuous Water Based Exercise in Hypertensive Older Individuals [NA]
This clinical trial update reports ongoing recruitment for a study comparing high-intensity interval water-based exercise to moderate-intens…
-
FDA approval · 2025-07-25FDA Approved: SPIRONOLACTONE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' generic spironolactone under an original application (ANDA 217761).
-
EMA approval · 2025-07-24EMA Authorised: Amlodipine / Valsartan Mylan (amlodipine besilate;valsartan) — Mylan Pharmaceuticals Limited
The European Medicines Agency has authorized a fixed-dose combination of amlodipine besilate and valsartan (Amlodipine / Valsartan Mylan) fo…
-
FDA approval · 2025-07-24FDA Approved: SDAMLO — Original Application (Pangea Pharmaceuticals, LLC)
The FDA approved SDAMLO (amlodipine) under an Original Application (NDA 219531) by Pangea Pharmaceuticals, LLC.
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
Duke University is conducting a clinical trial to address barriers to achieving cardiometabolic prevention and treatment goals for people li…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Study
A multi-center observational study evaluating the effectiveness and safety of Rozetel Tablet in patients after percutaneous coronary interve…
-
CLINICAL_TRIALS research · 2025-07-24Clinical Trial Update: Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems [NA]
This update notes that Reach Out 2, an emergency department-initiated hypertension mobile health intervention connecting multiple health sys…